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Probiotic research for diabetes preventionCurrent estimates suggest that 382 million individuals suffer
from diabetes worldwide. More importantly, the numbers could
potentially rise to 592 million by 2035 [1]. Recent statistics sug-
gest that the number of individuals with type 2 diabetes mellitus
(T2DM) is on the rise in every country. Low- and middle-income
countries constitute 80% of people with diabetes. Around 5.1
million deaths were due to diabetes in 2013; every 6 sec a person
dies from diabetes [1]. The global prevalence of prediabetes is
also increasing enormously, with >470 million people estimated
to suffer from prediabetes by 2030 [2].
Diabetes prevention programs (DPPs) have largely enrolled in-
dividualswithuntreatedprediabetesbecausew11%ofprediabetics
become diabetic every year. Therefore, there is every reason to
believe that actual prevention of diabetes and its complications
probably reside inthereversalofprediabetes.Diverse interventions
havebeen evaluated, including pharmacologic, lifestyle, andherbal
remedies. DPPs have shown the effectiveness of both metformin
therapy and intensive lifestyle intervention in delaying or prevent-
ing T2DM [3]. Nevertheless, the efﬁcacy of these interventions re-
mains uncertain. Moreover, interventions that work in certain
societiesmay not be effective in others because of social, economic,
and cultural variations. This is a concern in countries like India,
where there is great regional and ethnic diversity in lifestyle pat-
terns coupledwith a high prevalence of diabetes. The Indianpopu-
lace also faces a wide range of problems such as younger age of
diabetesonset, highersusceptibility todiabetesata relatively lower
bodymass index (BMI), higher rates of insulin resistance, and lower
thresholds for diabetes risk factors [4]. For the reasons cited here,
there is a need to expand research on prevention of T2DM.
There is considerable evidence for the effectiveness of probiot-
ics in improving insulin resistance, impaired insulin secretion, and
metabolic defects predicting T2DM [5]. The hypothesis that such
treatment can prevent T2DM in prediabetics has not been tested
previously. The minimal side effects of probiotics provide a
considerable advantage over many of the current pharmacologic
approaches to the treatment of prediabetes and T2DM such as
greater glycemic control and the potential to target different path-
ologic mechanisms involved in glucose dysregulations.
Commensal gut microbes modulate host metabolism by
affectingenergyextraction fromfoodandbybiochemicallyconvert-
ing molecules derived from the host or from gut microbes them-
selves. Changes in the microbial population within the gut alter
metabolism that can potentially promote obesity, metabolic syn-
drome, and T2DM [5,6]. High-quality animal studies have demon-
strated that modulating gut microbiota composition can regulate
gut permeability, plasma endotoxin levels, fat gain, inﬂammation,
and glucose tolerance. Modulation of gut microbiota has demon-
strated an improvement in glucose tolerance of mice by altering0899-9007/$ - see front matter  2015 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.nut.2014.06.014the gene expressions involved in inﬂammation. One study demon-
strated that a daily doseof probioticsmayprevent insulin resistance
andweight gain inmice [7]. Another study reported that consump-
tion of a symbiotic shake resulted in a signiﬁcant decrease in fasting
glycaemia in T2DM patients [8]. It has been reported that probiotic
yogurt consumption improved antioxidant status and fasting blood
glucose in T2DM [9]. There is also a body of increasing evidence of
the anti-obesity effects of probiotics [10]. All these positive ﬁndings
support the potential use of dietary supplements such as probiotics
to alleviate the development of metabolic disorders.
Despite abundant data on the mechanism of action and the
beneﬁcial effects of probiotics, it is very hard to draw an exact
conclusion from these trials because of the heterogeneity of the
patient populations studied. Although beneﬁcial effects have
been reported for lipid proﬁles, glucose metabolism, and insulin
resistance, there is no data on prevention of T2DM. There remains
a need for well-designed, controlled, sufﬁciently powered studies
that will reﬂect the actual role of probiotics in T2DM prevention.References
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